Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report.
CST, Community State Type
Co-infection
HPV, Human papillomavirus
HSV-2, Herpes Simplex Virus-2
Herpes Simplex Virus-2
Human papillomavirus
Interaction
STI, Sexually Transmitted Infection
Vaginal microbiota
qPCR
qPCR, quantitative PCRs
Journal
IDCases
ISSN: 2214-2509
Titre abrégé: IDCases
Pays: Netherlands
ID NLM: 101634540
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
07
2022
revised:
12
08
2022
accepted:
17
08
2022
entrez:
19
9
2022
pubmed:
20
9
2022
medline:
20
9
2022
Statut:
epublish
Résumé
Human papillomaviruses (HPVs), the most oncogenic virus known to humans, are often associated with Herpes Simplex Virus-2 (HSV-2) infections. The involvement of the latter in cervical cancer is controversial but its long-term infections might modulate the mucosal microenvironment in a way that favors carcinogenesis. We know little about coinfections between HSV-2 and HPVs, and studying the immunological and microbiological dynamics in the early stages of these infections may help identify or rule out potential interactions. We report two cases of concomitant productive, although asymptomatic, HSV-2 and HPV infections in young women (aged 20 and 25). The women were followed up for approximately a year, with clinical visits every two months and weekly self-samples. We performed quantitative analyses of their HSV-2 and HPV viral loads, immunological responses (IgG and IgM antibodies and local cytokines expression profiles), vaginal microbiota composition, as well as demographic and behavior data. We detect interactions between virus loads, immune response, and the vaginal microbiota, which improve our understanding of HSV-2 and HPVs' coinfections and calls for further investigation with larger cohorts.
Identifiants
pubmed: 36119756
doi: 10.1016/j.idcr.2022.e01604
pii: S2214-2509(22)00232-3
pmc: PMC9478384
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e01604Informations de copyright
© 2022 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: TW serves on advisory boards for MSD (Merck) Sharp & Dohme.
Références
J Infect Dis. 2014 Dec 1;210(11):1723-33
pubmed: 24943724
N Engl J Med. 2013 Dec 12;369(24):2324-31
pubmed: 24328466
Nat Commun. 2020 Feb 26;11(1):940
pubmed: 32103005
Clin Chem. 2005 Oct;51(10):1845-53
pubmed: 16099939
Vaccine. 2020 Dec 3;38(51):8167-8174
pubmed: 33168348
BJOG. 2020 Jan;127(2):182-192
pubmed: 31749298
J Natl Cancer Inst. 2011 Oct 5;103(19):1444-51
pubmed: 21908768
Arch Gynecol Obstet. 2014 Dec;290(6):1059-66
pubmed: 25030659
Microbiome. 2020 Nov 23;8(1):166
pubmed: 33228810
Nat Microbiol. 2022 Mar;7(3):367-378
pubmed: 35246662
J Infect Dis. 2017 May 1;215(9):1366-1375
pubmed: 28201724
Clin Microbiol Rev. 2016 Jan;29(1):149-61
pubmed: 26561565
J Infect Dis. 2011 Apr 1;203(7):910-20
pubmed: 21402543
Immunol Res. 2021 Jun;69(3):255-263
pubmed: 33939124
Bull World Health Organ. 2020 May 01;98(5):315-329
pubmed: 32514197
J Infect Dis. 2008 Oct 15;198(8):1141-9
pubmed: 18783315
BMJ Open. 2019 Jun 11;9(6):e025129
pubmed: 31189673
J Virol. 2017 Nov 14;91(23):
pubmed: 28956763